Global Erlotinib Hydrochloride Market
128 Pages | Healthcare

Global Erlotinib Hydrochloride Market Research Report 2018-2028

  • Published Date : 14-12-2021
  • Pages : 128
  • Report Id : 61431
  • Categories : Healthcare

Summary
Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells and slows their spread in the body
The global Erlotinib Hydrochloride market will reach xxx Million USD in 2022 with CAGR xx% 2022-2028. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
25mg
100mg
150mg
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Roche
Cipla
Mylan
Teva
OSI Pharmaceuticals
Glenmark Pharmaceuticals
Beacon Pharmaceuticals
Raichem Lifesciences
United Biotech
CJ Corporation
Vivimed Labs
Boryung Pharmaceutical
Taj Pharmaceuticals
Pharmascience
Natco Pharma
Intas Pharmaceuticals
RPG Life Sciences
Pharmascience
Schwarz Pharma
Dr. Reddy s Laboratories
Glenmark Pharmaceuticals
Chugai Pharmaceutical
DKSH
Firma Chun Cheong
Kremers Urban Pharmaceuticals
Ortat
Zuellig Pharma
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Non-small Cell Lung Cancer
Pancreatic Cancer
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa


Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Erlotinib Hydrochloride Picture
1.1.2 Specifications
Table Product Specifications of Erlotinib Hydrochloride
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Erlotinib Hydrochloride
Table Global Erlotinib Hydrochloride Market by Type, 2018-2028 (USD Million)
1.2.1.1 25mg
Table 25mg Overview
1.2.1.2 100mg
Table 100mg Overview
1.2.1.3 150mg
Table 150mg Overview
1.2.2 by Application
Table Application Segment of Erlotinib Hydrochloride
Table Global Erlotinib Hydrochloride Market by Application, 2018-2028 (USD Million)
1.2.2.1 Non-small Cell Lung Cancer
Table Non-small Cell Lung Cancer Overview
1.2.2.2 Pancreatic Cancer
Table Pancreatic Cancer Overview
1.2.3 by Regions
Table Global Erlotinib Hydrochloride Market by Region, 2018-2028 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Erlotinib Hydrochloride
2.2 Upstream
Table Cost of Erlotinib Hydrochloride
Figure Manufacturing Process of Erlotinib Hydrochloride
2.3 Market
2.3.1 SWOT
Figure SWOT of Erlotinib Hydrochloride
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Erlotinib Hydrochloride
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Erlotinib Hydrochloride
3.4 Market Entry
Table Market Entry of Erlotinib Hydrochloride
4 Market Segmentation by Type
4.1 Market Size
4.1.1 25mg Market, 2017-2021
Figure 25mg Market Size and Growth, 2017-2021 (USD Million)
Figure 25mg Market Size and Growth, 2017-2021 (in Volume)
Table 25mg CAGR by Revenue and Volume, 2017-2021
4.1.2 100mg Market, 2017-2021
Figure 100mg Market Size and Growth, 2017-2021 (USD Million)
Figure 100mg Market Size and Growth, 2017-2021 (in Volume)
Table 100mg CAGR by Revenue and Volume, 2017-2021
4.1.3 150mg Market, 2017-2021
Figure 150mg Market Size and Growth, 2017-2021 (USD Million)
Figure 150mg Market Size and Growth, 2017-2021 (in Volume)
Table 150mg CAGR by Revenue and Volume, 2017-2021
4.2 Market Forecast
4.2.1 25mg Market Forecast, 2022-2028
Figure 25mg Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure 25mg Market Estimates and Forecasts, 2022-2028 (in Volume)
Table 25mg CAGR by Revenue and Volume, 2018-2028
4.2.2 100mg Market Forecast, 2022-2028
Figure 100mg Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure 100mg Market Estimates and Forecasts, 2022-2028 (in Volume)
Table 100mg CAGR by Revenue and Volume, 2018-2028
4.2.3 150mg Market Forecast, 2022-2028
Figure 150mg Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure 150mg Market Estimates and Forecasts, 2022-2028 (in Volume)
Table 150mg CAGR by Revenue and Volume, 2018-2028
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Non-small Cell Lung Cancer Market, 2017-2021
Figure Non-small Cell Lung Cancer Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Non-small Cell Lung Cancer CAGR by Revenue and Volume, 2017-2021
5.1.2 Pancreatic Cancer Market, 2017-2021
Figure Pancreatic Cancer Market Size and Growth, 2017-2021 (USD Million)
Figure Market Size and Growth, 2017-2021 (in Volume)
Table Pancreatic Cancer CAGR by Revenue and Volume, 2017-2021
5.2 Market Forecast
5.2.1 Non-small Cell Lung Cancer Market Forecast, 2022-2028
Figure Non-small Cell Lung Cancer Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Non-small Cell Lung Cancer Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Non-small Cell Lung Cancer CAGR by Revenue and Volume, 2022-2028
5.2.2 Pancreatic Cancer Market Forecast, 2022-2028
Figure Pancreatic Cancer Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Pancreatic Cancer Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Pancreatic Cancer CAGR by Revenue and Volume, 2022-2028
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2017-2021
Figure Asia-Pacific Market Size and Growth, 2017-2021 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2017-2021 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2017-2021
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2017-2021
Figure North America Market Size and Growth, 2017-2021 (USD Million)
Figure North America Market Size and Growth, 2017-2021 (in Volume)
Table North America CAGR by Revenue and Volume, 2017-2021
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2017-2021
Figure Europe Market Size and Growth, 2017-2021 (USD Million)
Figure Europe Market Size and Growth, 2017-2021 (in Volume)
Table Europe CAGR by Revenue and Volume, 2017-2021
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2017-2021
Figure South America Market Size and Growth, 2017-2021 (USD Million)
Figure South America Market Size and Growth, 2017-2021 (in Volume)
Table South America CAGR by Revenue and Volume, 2017-2021
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2017-2021
Figure Middle East & Africa Market Size and Growth, 2017-2021 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2017-2021 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2017-2021
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2022-2028
Figure Asia-Pacific Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2022-2028
6.2.2 North America Market Forecast, 2022-2028
Figure North America Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure North America Market Estimates and Forecasts, 2022-2028 (in Volume)
Table North America CAGR by Revenue and Volume, 2022-2028
6.2.3 Europe Market Forecast, 2022-2028
Figure Europe Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Europe Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Europe CAGR by Revenue and Volume, 2022-2028
6.2.4 South America Market Forecast, 2022-2028
Figure South America Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure South America Market Estimates and Forecasts, 2022-2028 (in Volume)
Table South America CAGR by Revenue and Volume, 2022-2028
6.2.5 Middle East & Africa Market Forecast, 2022-2028
Figure Middle East & Africa Market Estimates and Forecasts, 2022-2028 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2022-2028 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2022-2028
7 Market Competitive
7.1 Global Market by Vendors
Table Global Erlotinib Hydrochloride Market by Vendors, 2017-2021 (in Volume)
Table Global Erlotinib Hydrochloride Market Share by Vendors, 2017-2021 (USD Million)
Table Global Erlotinib Hydrochloride Market Share by Vendors, 2017-2021 (in Volume)
7.2 Market Concentration
Figure Erlotinib Hydrochloride Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Roche
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Cipla
Table Cipla Profile List
Table Microecological Modulator Operating Data of Cipla (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Mylan
Table Mylan Profile List
Table Microecological Modulator Operating Data of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Teva
Table Teva Profile List
Table Microecological Modulator Operating Data of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 OSI Pharmaceuticals
Table OSI Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of OSI Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Glenmark Pharmaceuticals
Table Glenmark Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Glenmark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Beacon Pharmaceuticals
Table Beacon Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Beacon Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Raichem Lifesciences
Table Raichem Lifesciences Profile List
Table Microecological Modulator Operating Data of Raichem Lifesciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 United Biotech
Table United Biotech Profile List
Table Microecological Modulator Operating Data of United Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 CJ Corporation
Table CJ Corporation Profile List
Table Microecological Modulator Operating Data of CJ Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 Vivimed Labs
Table Vivimed Labs Profile List
Table Microecological Modulator Operating Data of Vivimed Labs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 Boryung Pharmaceutical
Table Boryung Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Boryung Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.13 Taj Pharmaceuticals
Table Taj Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Taj Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.14 Pharmascience
Table Pharmascience Profile List
Table Microecological Modulator Operating Data of Pharmascience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.15 Natco Pharma
Table Natco Pharma Profile List
Table Microecological Modulator Operating Data of Natco Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.16 Intas Pharmaceuticals
Table Intas Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Intas Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.17 RPG Life Sciences
Table RPG Life Sciences Profile List
Table Microecological Modulator Operating Data of RPG Life Sciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.18 Pharmascience
Table Pharmascience Profile List
Table Microecological Modulator Operating Data of Pharmascience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.19 Schwarz Pharma
Table Schwarz Pharma Profile List
Table Microecological Modulator Operating Data of Schwarz Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.20 Dr. Reddy’s Laboratories
Table Dr. Reddy’s Laboratories Profile List
Table Microecological Modulator Operating Data of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.21 Glenmark Pharmaceuticals
Table Glenmark Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Glenmark Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.22 Chugai Pharmaceutical
Table Chugai Pharmaceutical Profile List
Table Microecological Modulator Operating Data of Chugai Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.23 DKSH
Table DKSH Profile List
Table Microecological Modulator Operating Data of DKSH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.24 Firma Chun Cheong
Table Firma Chun Cheong Profile List
Table Microecological Modulator Operating Data of Firma Chun Cheong (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.25 Kremers Urban Pharmaceuticals
Table Kremers Urban Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Kremers Urban Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.26 Ortat
Table Ortat Profile List
Table Microecological Modulator Operating Data of Ortat (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.27 Zuellig Pharma
Table Zuellig Pharma Profile List
Table Microecological Modulator Operating Data of Zuellig Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion

Direct Purchase
Your perfect start with Research Allied


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo
×

Avail PDF Sample Reports

You may also be lnterested in..

Research Allied Copyright © 2024 .